ClinConnect ClinConnect Logo
Search / Trial NCT06318026

Systematic Implementation of Patient-centered Care for Alcohol Use Trial: Beyond Referral to Treatment

Launched by KAISER PERMANENTE · Mar 12, 2024

Trial Information

Current as of August 27, 2025

Recruiting

Keywords

Patient Centered Care Shared Decision Making Population Based Management Quality Improvement Decision Aid

ClinConnect Summary

The Systematic Implementation of Patient-centered Care for Alcohol Use Trial is a research study aimed at improving how we help people with alcohol use problems. This trial will test two new approaches to care in about 25 primary care clinics. The goal is to better support patients by involving them in decisions about their treatment, making it more personalized to their needs. Participants will be divided into groups to receive either the usual care they typically get, one of the new care approaches, or another centralized support option.

To join the study, you need to be an adult aged 18 or older and have certain symptoms related to alcohol use, as measured by a checklist. Specifically, you should have at least four symptoms or two to three symptoms along with a high-risk drinking score. Importantly, this trial is not yet recruiting participants, but it will include all genders. If you decide to take part, you can expect to receive support tailored to your situation to help you manage your alcohol use effectively.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Adult primary care patients ≥18 years old on the day of a primary care appointment; and
  • 2. ≥4 symptoms on the Alcohol Symptom Checklist, or 2-3 symptoms on the Alcohol Symptom Checklist with at least one symptom associated with high risk of progression to severe symptoms, documented in the electronic health record associated with the primary care appointment; and
  • 3. high-risk drinking on the alcohol screening questionnaire (AUDIT-C ≥7) on the day of the Alcohol Symptom Checklist or in the prior 30 days documented in the electronic health record.
  • Exclusion Criteria:
  • 1. Documented request to not participate in research, or
  • 2. Patient was eligible for the Vanguard pilot study.

About Kaiser Permanente

Kaiser Permanente is a leading integrated health care organization that combines a health plan with a network of hospitals and physicians to provide comprehensive medical services. With a strong commitment to advancing medical research and improving patient care, Kaiser Permanente sponsors clinical trials across various therapeutic areas. The organization emphasizes innovative approaches to health care, leveraging its extensive data and resources to support evidence-based treatments and enhance patient outcomes. Through its rigorous research initiatives, Kaiser Permanente aims to contribute to the advancement of medical knowledge and the development of new therapies that benefit diverse populations.

Locations

Seattle, Washington, United States

Seattle, Washington, United States

Patients applied

0 patients applied

Trial Officials

Katharine Bradley, MD, MPH

Principal Investigator

Kaiser Permanente

Gwen Lapham, PhD, MPH, MSW

Principal Investigator

Kaiser Permanente

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported